Company Overview

Cypralis is privately held and started as a spinout from Selcia Ltd. in 2012. The founders are experts of combined 50 years of experience in the biology of cyclophilins and the chemistry of their inhibitors. Our headquarters is at St John's Innovation Centre, Cambridge, UK. We operate a virtual model, using CROs and academic collaborations to conduct early discovery and pre-clinical activities. Pre-clinical and clinical development is done in China through our partnership with Farsight Medical Technology (Shanghai) CO., Ltd.